JD Health International Inc. (HKG:6618)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
39.50
-0.02 (-0.05%)
Aug 14, 2026, 4:08 PM HKT

JD Health International Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, JD Health International stock has a consensus rating of "Strong Buy" and an average price target of $68.89. The average 1-year stock price forecast is 74.41% higher than the current stock price, while the lowest is $49.60 (+25.57%) and the highest is $95.37 (+141.44%).

Price Target: $68.89 (+74.41%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$49.60$68.89$67.28$95.37
Change+25.57%+74.41%+70.33%+141.44%

Analyst Ratings

The average analyst rating for JD Health International stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy151514141414
Buy233333
Hold211111
Sell000000
Strong Sell000000
Total191918181818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$66.20
BuyMaintains$66.20+67.59%Aug 15, 2026
Unknown Analyst
CLSA
No rating
CLSA
Buy
Maintains
$61.00
BuyMaintains$61.00+54.43%Aug 15, 2026
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Buy
Maintains
$68.00$57.00
BuyMaintains$68.00$57.00+44.30%Aug 15, 2026
Unknown Analyst
Goldman Sachs
No rating
Goldman Sachs
Buy
Maintains
$65.00
BuyMaintains$65.00+64.56%Jul 17, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$70.70$61.90
BuyMaintains$70.70$61.90+56.71%Jul 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
86.03B
from 73.44B
Increased by 17.14%
Revenue Next Year
99.36B
from 86.03B
Increased by 15.50%
EPS This Year
2.10
from 2.04
Increased by 2.61%
EPS Next Year
2.51
from 2.10
Increased by 19.54%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
30.68B46.74B53.53B58.16B73.44B86.03B
Revenue Growth
58.30%52.32%14.54%8.65%26.28%17.14%
Gross Profit
7.20B9.89B11.87B13.31B18.20B21.80B
Gross Margin
23.46%21.16%22.17%22.88%24.78%25.34%
Operating Income
-1.40B-145.12M630.85M1.16B3.80B5.19B
Net Income
-1.07B380.11M2.14B4.16B5.38B5.86B
EPS
----2.042.10
EPS Growth
----34.79%2.61%
Forward PE
112.3267.4026.4117.6024.3716.18
Free Cash Flow
3.22B3.16B2.75B2.35B7.24B7.26B
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High87.0B
Avg86.0B
Low85.2B

Revenue Growth

Revenue Growth202620272028
High
18.4%
Avg
17.1%
Low
16.0%

EPS Forecast

EPS202620272028
High2.19
Avg2.10
Low1.89

EPS Growth

EPS Growth202620272028
High
7.1%
Avg
2.6%
Low
-7.5%